当前位置: 首页 > 期刊 > 《心脑血管病防治》 > 20201
编号:13510821
急性心肌梗死患者PCI后发生心血管事件的危险因素分析(3)
http://www.100md.com 2020年2月1日 《心脑血管病防治》 20201
     [9] Velu K, Ramesh R, Medha R, et al. Role of serum microRNA-499 as a diagnostic marker in acute myocardial infarction (AMI)[J]. Cor Et Vasa, 2018, 7(3):303-308 .

    [10] Shyu K G , Wang B W , Cheng W P , et al. MicroRNA-208a increases myocardial endoglin expression and myocardial fibrosis in acute myocardial infarction[J]. Can J Cardiol., 2015, 31(5):679-690.

    [11] 中國医师协会中西医结合医师分会,急性心肌梗死中西医结合诊疗指南[J].中国中西医结合杂志,2018,38(3):272-284.

    [12] Busch A, Eken S M, Maegdefessel L. Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease[J]. Ann Transl Med, 2016, 4(12):236.

    [13] Zhang Y, Li H H, Yang R, et al. Association between circulating microRNA-208a and severity of coronary heart disease[J]. Scand J Clin Lab Invest, 2017, 77(5):379-384.

    [14] Xiao J, Shen B, Li J, et al. Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarction[J]. Int J Clin Exp Med, 2014, 7(1):136-141.

    [15] Cui HB, Ge HE, Wang YS, et al. MiR-208a enhances cell proliferation and invasion of gastric cancer by targeting SFRP1 and negatively regulating MEG3[J]. Int J Biochem Cell Biol, 2018, 102:31-39.

    (收稿日期:2019-05-14)

    (本文编辑:蒋爱敏), http://www.100md.com(张赞伟 胡小菁 魏文扬)
上一页1 2 3